Selected article for: "acute respiratory syndrome and rapid human human transmission"
Author: Qiang Huang; Andreas Herrmann
Title: Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV)
  • Document date: 2020_2_3
    • ID: eecyduzq_3
    Snippet: In December 2019, a novel CoV (2019-nCoV) emerged from Wuhan, China, and spread rapidly to other areas (Holshue et al., 2020; Li et al., 2020; Wu et al., 2020; Zhou et al., 2020) . Although its original host remains unknown, all available data point again to a wild animal source. And, it is evident that human-to-human transmission is causing the rapid spreading of this newly emerged virus. Viral strains from infected persons of the area have been.....
    Document: In December 2019, a novel CoV (2019-nCoV) emerged from Wuhan, China, and spread rapidly to other areas (Holshue et al., 2020; Li et al., 2020; Wu et al., 2020; Zhou et al., 2020) . Although its original host remains unknown, all available data point again to a wild animal source. And, it is evident that human-to-human transmission is causing the rapid spreading of this newly emerged virus. Viral strains from infected persons of the area have been sequenced; but only little genetic variation was found, implying that they are descended from a common ancestor (Rambaut, 2020) . Full-length genome analysis of 2019-nCoV patient samples revealed 79.5% and 96% sequence identities to SARS-CoV and a bat SARSr-Cov (severe acute respiratory syndrome-related CoV), respectively; however, sequences of the seven conserved viral replicase domains in ORF1ab show 94.6% identity between 2019-nCoV and SARS-CoV .

    Search related documents:
    Co phrase search for related documents
    • animal source and genome analysis: 1, 2, 3, 4, 5
    • animal source and human human: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • animal source and human human transmission: 1, 2, 3, 4, 5, 6, 7, 8
    • animal source and novel cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • area infected person and infected person: 1, 2, 3, 4
    • available data point and data point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • common ancestor and data point: 1
    • common ancestor and genetic variation: 1, 2, 3
    • common ancestor and genome analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • common ancestor and human human: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • common ancestor and human human transmission: 1
    • common ancestor and novel cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • data point and genetic variation: 1, 2
    • data point and human human: 1, 2, 3
    • data point and human human transmission: 1, 2
    • data point and infected person: 1
    • data point and novel cov: 1, 2, 3, 4, 5
    • genetic variation and genome analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • genetic variation and human human: 1, 2, 3, 4, 5, 6, 7, 8, 9